UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

Groszmann, RJ; Garcia-Tsao, G; Bosch, J; Grace, ND; Burroughs, AK; Planas, R; Escorsell, A; ... Portal Hypertension Collaborative Group; + view all (2005) Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med , 353 (21) pp. 2254-2261. 10.1056/NEJMoa044456. Green open access

[thumbnail of 7295.pdf]
Preview
PDF
7295.pdf

Download (149kB)

Abstract

BACKGROUND: Nonselective beta-adrenergic blockers decrease portal pressure and prevent variceal hemorrhage. Their effectiveness in preventing varices is unknown. METHODS: We randomly assigned 213 patients with cirrhosis and portal hypertension (minimal hepatic venous pressure gradient [HVPG] of 6 mm Hg) to receive timolol, a nonselective beta-blocker (108 patients), or placebo (105 patients). The primary end point was the development of gastroesophageal varices or variceal hemorrhage. Endoscopy and HVPG measurements were repeated yearly. RESULTS: During a median follow-up of 54.9 months, the rate of the primary end point did not differ significantly between the timolol group and the placebo group (39 percent and 40 percent, respectively; P=0.89), nor were there significant differences in the rates of ascites, encephalopathy, liver transplantation, or death. Serious adverse events were more common among patients in the timolol group than among those in the placebo group (18 percent vs. 6 percent, P=0.006). Varices developed less frequently among patients with a baseline HVPG of less than 10 mm Hg and among those in whom the HVPG decreased by more than 10 percent at one year and more frequently among those in whom the HVPG increased by more than 10 percent at one year. CONCLUSIONS: Nonselective beta-blockers are ineffective in preventing varices in unselected patients with cirrhosis and portal hypertension and are associated with an increased number of adverse events. (ClinicalTrials.gov number, NCT00006398.)

Type: Article
Title: Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1056/NEJMoa044456
Keywords: Adrenergic beta-Antagonists, Adult, Double-Blind Method, Esophageal and Gastric Varices, Female, Gastrointestinal Hemorrhage, Heart Rate, Humans, Hypertension, Portal, Liver Cirrhosis, Male, Middle Aged, Timolol, Treatment Failure
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
URI: https://discovery.ucl.ac.uk/id/eprint/7295
Downloads since deposit
1,509Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item